Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Brain scan Tune-Up: healthy volunteers help researchers recalibrate MRI machines

NCT ID NCT07453108

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study involves 40 healthy volunteers aged 18 to 86 who will undergo MRI brain scans and transcranial magnetic stimulation (TMS). The goal is to collect reference data to recalibrate the hospital's MRI scanner after an upgrade. No treatment or drug is being tested; the results will support future research on neuropsychiatric disorders.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 40 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2023

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 86 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Men or women aged 18 to 86 inclusive; * Affiliated to a social health insurance scheme * Able to understand the objectives and risks of the research and to give dated and signed informed consent; * B2 or above level of French language according to the European Framework of Reference for Languages; * No personal or family psychiatric history of endogenous psychosis, including substance abuse (excluding moderate tobacco, alcohol and caffeine use); * No chronic pathology requiring treatment (mainly diabetes, hypertension, hyperlipidemia or cholesterolemia); * Matched on age, gender and education level of the patients included in our different studies * Woman of childbearing age: negative urine pregnancy test at the inclusion visit and effective contraception throughout the study (intrauterine device, sterilisation, oestrogen or progestin per os, injectable or as an implant or ring). Exclusion Criteria: * Contraindication to MRI or rTMS: presence of a non-removable ferromagnetic foreign body, prosthesis, pacemaker, medication delivered by an implanted pump, vascular clip or stent, heart valve or ventricular bypass, epilepsy; * History that may affect brain anatomy or be related to an abnormality (neurosurgery, epilepsy, stroke, head injury with loss of consciousness for more than 15 minutes and mental retardation - Intelligence Quotient (IQ) \< 70 on the fNART); * History of potentially affecting brain function (general anaesthesia or Electroconvulsive Therapy (ECT) \< 3 months prior to inclusion); * Breastfeeding women ; * Pregnant women ; * Serious or unstabilised somatic pathology ; * Chronic intake of a treatment related to an ongoing disease; * Deprived of liberty, in forced care or under legal protection ; * Under guardianship or curatorship ; * Emergency or life-threatening situation) ; * Exclusion period (determined by a previous or current study).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Neuropsychiatric disorders are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Les Hôpitaux Universitaires

    Strasbourg, Bas-Rhin, 67091, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.